XML 80 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814
BUSINESS ACQUISITIONS - Schedule of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Jul. 17, 2015
Dec. 31, 2014
Jan. 15, 2014
Business Acquisition [Line Items]        
Goodwill $ 505,727   $ 363,479  
TEI Biosciences Inc and TEI Medical Inc.        
Business Acquisition [Line Items]        
Cash 1,241 $ 1,200    
Accounts receivable, net 9,011      
Inventory 23,223      
Income tax receivable 5,135      
Other current assets 2,270      
Fixed assets 2,027      
Goodwill 148,935      
Total assets acquired 410,656      
Deferred tax liabilities - long term 88,565      
Accounts payable and other liabilities 9,732      
Net assets acquired 312,359      
TEI Biosciences Inc and TEI Medical Inc. | Developed Technology Rights        
Business Acquisition [Line Items]        
Finite intangible assets $ 167,400      
TEI Biosciences Inc and TEI Medical Inc. | Developed Technology Rights | Minimum        
Business Acquisition [Line Items]        
Weighted average useful life 14 years      
TEI Biosciences Inc and TEI Medical Inc. | Developed Technology Rights | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 16 years      
TEI Biosciences Inc and TEI Medical Inc. | Customer relationships        
Business Acquisition [Line Items]        
Finite intangible assets $ 51,345      
TEI Biosciences Inc and TEI Medical Inc. | Customer relationships | Minimum        
Business Acquisition [Line Items]        
Weighted average useful life 11 years      
TEI Biosciences Inc and TEI Medical Inc. | Customer relationships | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 14 years      
TEI Biosciences Inc and TEI Medical Inc. | Leasehold Interest        
Business Acquisition [Line Items]        
Finite intangible assets $ 69      
Metasurg        
Business Acquisition [Line Items]        
Inventory 4,800      
Fixed assets 1,246      
Goodwill 732      
Net assets acquired 27,558      
Metasurg | In Process Research and Development        
Business Acquisition [Line Items]        
Indefinite intangible assets 190      
Metasurg | Technology-Based Intangible Assets        
Business Acquisition [Line Items]        
Finite intangible assets $ 20,590      
Metasurg | Technology-Based Intangible Assets | Minimum        
Business Acquisition [Line Items]        
Weighted average useful life 8 years      
Metasurg | Technology-Based Intangible Assets | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 14 years      
Medtronic MicroFrance        
Business Acquisition [Line Items]        
Cash $ 2,195      
Inventory 3,155      
Inventory deposit 620      
Other current assets 5,025      
Fixed assets 3,675      
Goodwill 16,607      
Total assets acquired 65,977      
Accounts payable and other liabilities 5,910      
Net assets acquired 60,067      
Medtronic MicroFrance | Trade Names        
Business Acquisition [Line Items]        
Finite intangible assets $ 11,990      
Medtronic MicroFrance | Trade Names | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 20 years      
Medtronic MicroFrance | Technology-Based Intangible Assets        
Business Acquisition [Line Items]        
Finite intangible assets $ 4,580      
Medtronic MicroFrance | Technology-Based Intangible Assets | Minimum        
Business Acquisition [Line Items]        
Weighted average useful life 15 years      
Medtronic MicroFrance | Technology-Based Intangible Assets | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 16 years      
Medtronic MicroFrance | Customer relationships        
Business Acquisition [Line Items]        
Finite intangible assets $ 18,130      
Medtronic MicroFrance | Customer relationships | Minimum        
Business Acquisition [Line Items]        
Weighted average useful life 12 years      
Medtronic MicroFrance | Customer relationships | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 16 years      
Confluent Surgical, Inc.        
Business Acquisition [Line Items]        
Inventory deposit $ 4,000      
Fixed assets 438      
Deferred tax assets - long term 12      
Goodwill 105,331      
Total assets acquired 349,981      
Contingent supply liability 5,891      
Other 731      
Deferred tax liabilities - long term 87,464      
Net assets acquired $ 255,895     $ 255,895
Confluent Surgical, Inc. | Technology-Based Intangible Assets | Minimum        
Business Acquisition [Line Items]        
Weighted average useful life 3 years      
Confluent Surgical, Inc. | Technology-Based Intangible Assets | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 20 years      
Confluent Surgical, Inc. | Developed Technology Rights        
Business Acquisition [Line Items]        
Finite intangible assets $ 239,800      
Confluent Surgical, Inc. | Other Intangible Assets        
Business Acquisition [Line Items]        
Finite intangible assets $ 400      
Confluent Surgical, Inc. | Other Intangible Assets | Maximum        
Business Acquisition [Line Items]        
Weighted average useful life 1 year